The role of exosomes in Pseudomonas Aeruginosa Corneal Infection

外泌体在铜绿假单胞菌角膜感染中的作用

基本信息

  • 批准号:
    10418656
  • 负责人:
  • 金额:
    $ 40.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Pseudomonas aeruginosa (PA) is the leading causative agent in microbial keratitis. During contact lens wear, host defense mechanisms are compromised. This allows PA to breach the tight corneal barrier and infect the otherwise healthy eye. Recently, exosomes have been implicated as major players in inflammation and infection. In addition, exosomes are becoming increasingly recognized as potential therapeutic agents. Our preliminary data shows that there is massive exosome release from corneal epithelial cells during infection by PA. These exosomes contain a unique mixture of proteases, transcriptional regulators and proteins involved in immune regulation. We further provide data that indicates that these exosomes both promote neutrophil activation and convey protection to corneal epithelial cells against further invasion. Moreover, we have found that exosomes isolated from autologous body fluids have antimicrobial and immunomodulatory properties. Based on our findings, we propose the primary hypothesis that exosomes released from PA-infected corneal epithelial cells promote PA clearance by innate immune cells and prime non-infected corneal epithelial cells to defend against PA infection. We further propose the secondary hypothesis that exosomes derived from exosome rich body fluids contain potent antimicrobial and anti-inflammatory mediators that can be harnessed to promote PA clearance and disease resolution in the cornea. We will test these hypotheses as follows: Aim 1. Establish how exosomes isolated from PA-infected corneal epithelial cells and human body fluids impact innate immune cells in vitro. Aim 2. Determine how exosomes isolated from PA-infected corneal epithelial cells and human body fluids impact the corneal epithelial response to PA in vitro. Aim 3. Determine whether exosomes isolated from autologous human body fluids exhibit protective antimicrobial and immunomodulatory properties in the rabbit contact lens model in vivo. To accomplish these studies, we have compiled a highly collaborative multidisciplinary team and have access to state of the art resources in the Department of Ophthalmology and UT Southwestern core facilities. These studies are significant and innovative because they are the first of their kind for PA infection in any tissue or cell system. The potential therapeutic use of exosomes from human body fluids represents a major paradigm shift for treating corneal infections and has broad therapeutic implications.
项目概要 铜绿假单胞菌 (PA) 是微生物性角膜炎的主要病原体。佩戴隐形眼镜期间, 宿主防御机制受到损害。这使得 PA 突破紧密的角膜屏障并感染 否则眼睛健康。最近,外泌体被认为是炎症和炎症的主要参与者。 感染。此外,外泌体越来越被认为是潜在的治疗剂。 我们的初步数据表明,感染期间角膜上皮细胞释放大量外泌体 由PA。这些外泌体含有独特的蛋白酶、转录调节因子和相关蛋白质的混合物 在免疫调节方面。我们进一步提供的数据表明这些外泌体都促进中性粒细胞 激活并保护角膜上皮细胞免受进一步侵袭。此外,我们还发现 从自体体液中分离出的外泌体具有抗菌和免疫调节特性。 根据我们的发现,我们提出主要假设:PA 感染的角膜释放外泌体 上皮细胞通过先天免疫细胞促进 PA 清除,并促使未感染的角膜上皮细胞 防御PA感染。我们进一步提出第二个假设,即外泌体来源于 富含外泌体的体液含有可利用的有效抗菌和抗炎介质 促进角膜 PA 清除和疾病解决。 我们将按如下方式测试这些假设: 目标 1. 确定如何从 PA 感染中分离外泌体 角膜上皮细胞和人体体液在体外影响先天免疫细胞。目标 2. 确定 从 PA 感染的角膜上皮细胞和人体液中分离出的外泌体如何影响 体外角膜上皮对 PA 的反应。目标 3. 确定外泌体是否从 自体人体液具有保护性抗菌和免疫调节特性 兔体内隐形眼镜模型。 为了完成这些研究,我们组建了一个高度协作的多学科团队,并拥有 眼科和 UT 西南核心设施拥有最先进的资源。这些 研究具有重要意义和创新性,因为它们是第一个针对 PA 感染的此类研究。 组织或细胞系统。人体体液外泌体的潜在治疗用途代表了 治疗角膜感染的重大范式转变,具有广泛的治疗意义。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The roles of autophagy and mitophagy in corneal pathology: current knowledge and future perspectives.
  • DOI:
    10.3389/fmed.2023.1064938
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIELLE M. ROBERTSON其他文献

DANIELLE M. ROBERTSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIELLE M. ROBERTSON', 18)}}的其他基金

The role of the intestinal microbiota in ocular surface health
肠道微生物群在眼表健康中的作用
  • 批准号:
    10532228
  • 财政年份:
    2021
  • 资助金额:
    $ 40.5万
  • 项目类别:
The role of the intestinal microbiota in ocular surface health
肠道微生物群在眼表健康中的作用
  • 批准号:
    10362438
  • 财政年份:
    2021
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cell Culture and Cell Phenotyping
细胞培养和细胞表型分析
  • 批准号:
    10216270
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
The role of exosomes in Pseudomonas Aeruginosa Corneal Infection
外泌体在铜绿假单胞菌角膜感染中的作用
  • 批准号:
    10166851
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cell Culture and Cell Phenotyping
细胞培养和细胞表型分析
  • 批准号:
    10657395
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cell Culture and Cell Phenotyping
细胞培养和细胞表型分析
  • 批准号:
    10438809
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
Effects of systemic disease on corneal epithelial pathophysiology
全身性疾病对角膜上皮病理生理学的影响
  • 批准号:
    9057553
  • 财政年份:
    2015
  • 资助金额:
    $ 40.5万
  • 项目类别:
Effects of systemic disease on corneal epithelial pathophysiology
全身性疾病对角膜上皮病理生理学的影响
  • 批准号:
    9467549
  • 财政年份:
    2015
  • 资助金额:
    $ 40.5万
  • 项目类别:
Effects of systemic disease on corneal epithelial pathophysiology
全身性疾病对角膜上皮病理生理学的影响
  • 批准号:
    10676145
  • 财政年份:
    2015
  • 资助金额:
    $ 40.5万
  • 项目类别:
Effects of systemic disease on corneal epithelial pathophysiology
全身性疾病对角膜上皮病理生理学的影响
  • 批准号:
    10249283
  • 财政年份:
    2015
  • 资助金额:
    $ 40.5万
  • 项目类别:

相似海外基金

New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
  • 批准号:
    1654774
  • 财政年份:
    2015
  • 资助金额:
    $ 40.5万
  • 项目类别:
    Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8416313
  • 财政年份:
    2012
  • 资助金额:
    $ 40.5万
  • 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8298885
  • 财政年份:
    2012
  • 资助金额:
    $ 40.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了